Perioperative blood transfusions. Value, risks, and guidelines;Perioperative bluttransfusion: Nutzen, risiken und richtlinien

Anaesthesist

Volumn 54, Issue 1, 2005, Pages 67-82

  Madjdpour, C ^a   Marcucci, C ^a   Tissot, J D ^b   Spahn, D R ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Blood transfusion; Normovolemic anemia; Oxygen transport capacity; Red blood cell unit; Transfusion trigger

Indexed keywords

HEMOGLOBIN; OXYGEN;

ANEMIA; ANESTHESIST; BLEEDING; BLOOD TRANSFUSION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); GEOGRAPHY; HEMOGLOBIN DETERMINATION; HUMAN; HYPOVOLEMIA; HYPOXEMIA; IMMUNOLOGY; LUNG INJURY; OXYGEN BLOOD LEVEL; OXYGEN SUPPLY; PEDIATRICS; PERIOPERATIVE PERIOD; PHYSIOLOGY; POSTOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; SURGICAL INJURY;

ADULT; BLOOD PRESERVATION; BLOOD TRANSFUSION; BLOOD VOLUME; CHILD; ERYTHROCYTE TRANSFUSION; GUIDELINES; HEART DISEASES; HUMANS; PERIOPERATIVE CARE; PLASMA SUBSTITUTES; POSTOPERATIVE COMPLICATIONS;

EID: 14244251822     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-004-0789-7     Document Type: Review

References (39)

1. Goodnough LT (2003) Risks of blood transfusion. Crit Care Med 31 [12 Suppl]: S678-686
2. Wagner SJ (2004) Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 86 (3): 157-163
3. Kleinman S, Chan P, Robillard P (2003) Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 17 (2): 120-162
4. Llewelyn CA et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (9407): 417-421
5. Peden AH et al. (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (9433): 527-529
6. Pincock S (2004) Government confirms second case of vCJD transmitted by blood transfusion. BMJ 329 (7460): 251
7. Goodnough LT et al. (1999) Transfusion medicine. First of two parts-blood transfusion. N Engl J Med 340 (6): 438-447
8. The Serious Hazards of Transfusion Steering Group (2003) Serious hazards of transfusion annual report 2003. http://www.shotuk.org/SHOT%20Report%202003. pdf, 5th July 2004
9. Webert KE, Blajchman MA (2003) Transfusion-related acute lung injury. Transfus Med Rev 17 (4): 252-262
10. Morisaki H, Sibbald WJ (2004) Tissue oxygen delivery and the microcirculation. Crit Care Clin 20 (2): 213-223
11. Viele MK, Weiskopf RB (1994) What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah's Witnesses. Transfusion 34 (5): 396-401
12. Weiskopf RB et al. (1998) Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 279 (3): 217-221
13. Practice Guidelines for blood component therapy (1996) A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84 (3): 732-747
14. Simon TL et al. (1998) Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 122 (2): 130-138
15. Spahn DR (1999) Benefits of red blood cell transfusion: Where is the evidence? TATM 1: 6-10
16. Hebert PC, McDonald BJ, Tinmouth A (2004) Clinical consequences of anemia and red cell transfusion in the critically ill. Crit Care Clin 20 (2): 225-235
17. Fitzgerald RD et al. (1997) Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 25 (5): 726-732
18. Nolte D et al. (1997) Effects of diaspirin-cross-linked hemoglobin (DCLHb) on local tissue oxygen tension in striated skin muscle: an efficacy study in the hamster. J Lab Clin Med 130 (3): 328-338
19. Casutt M et al. (1999) Factors influencing the individual effects of blood transfusion on oxygen delivery and oxygen consumption. Crit Care Med 27: 2194-2200
20. Sehgal LR et al. (2001) Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion 41 (5): 591-595
21. Napolitano LM, Corwin HL (2004) Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin 20 (2): 255-268
22. Spahn DR et al. (1996) Hemodilution tolerance in patients with coronary artery disease who are receiving chronic beta-adrenergic blocker therapy. Anesth Analg 82 (4): 687-694
23. Spahn DR, Casutt M (2000) Eliminating blood transfusions: New aspects and perspectives. Anesthesiology 93: 242-255
24. Spahn DR et al. (1997) Effects of chronic beta-blockade on compensatory mechanisms during acute isovolaemic haemodilution in patients with coronary artery disease. Br J Anaesth 78 (4): 381-385
25. Hebert PC et al. (2001) Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 29 (2): 227-234
26. Hebert PC, Fergusson DA (2004) Do transfusions get to the heart of the matter? JAMA 292 (13): 1610-1612
27. Rao SV et al. (2004) Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (13): 1555-1562
28. Licker M et al. (2004) Continuous haemodynamic monitoring using transoesophageal Doppler during acute normovolaemic haemodilution in patients with coronary artery disease. Anaesthesia 59 (2): 108-115
29. Spahn DR et al. (1998) Haemodilution tolerance in patients with mitral regurgitation. Anaesthesia 53 (1): 20-24
30. Weiskopf RB et al. (2000) Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 92 (6): 1646-1652
31. Spahn DR et al. (1996) Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 82 (4): 681-686
32. Raby KE et al. (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88 (3): 477-482
33. Desmet L, Lacroix J (2004) Transfusion in pediatrics. Crit Care Clin 20 (2): 299-311
34. Lacroix J, Tucci M, Gauvin F (2004) Red blood cell transfusion practices in pediatric critical care. TATM 6 (2): 22-26
35. Roseff SD, Luban NL, Manno CS (2002) Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42 (11): 1398-1413
36. Gregori L et al. (2004) Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. Lancet 364 (9433): 529-531
37. Marcucci C, Madjdpour C, Spahn DR (2004) Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull 70: 15-28
38. Spahn DR, Schanz U, Pasch T (1998) Perioperative transfusion criteria. Anaesthesist 47 (12): 1011-1020
39. Zwicky C et al. (1999) Prevention of post-transfusion cytomegalovirus infection: recommendations for clinical practice. Schweiz Med Wochenschr 129 (29-30): 1061-1066